Table 1 shows the drug-mediated inhibition of cell proliferation (MTT assay) and activation of apoptosis (Annexin V assay), comparing the effects of each drug combination with the individual drugs in the breast cancer (MDA-MB-231 and MCF-7) and ovarian cancer (HEY-T30 and SKOV-3) cell lines. Here, ANXA5 is linked to ovarian carcinoma.